DMC Biotechnologies

Series-B
dmcbio.com Biotech & Healthcare Durham
Total Funding $18M
Latest Round $18M Series-B
Last Announced Oct 26, 2026
Investors 8 Backers
Decision Makers 6 Available

About DMC Biotechnologies

DMC Biotechnologies produces bio-based chemicals using fermentation.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters Durham
Tracked Since Oct 26, 2026

Web & Domain Identity

Official Website dmcbio.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $18,000,000 · Series-B

    Backed by Inceptional Partners

Investors & Backers

8
Inceptional Partners
Lead
Boulder Ventures
Capricorn Partners
Cibus Fund
First Bight Ventures
Michelin Ventures
SCG Holdings
Sofinnova Partners

Funding History

1 Round
Series-B equity · Oct 26, 2026

Round backers: Inceptional Partners

$18,000,000 lnkd.in

Founders & Leadership

3

James Flatt

CEO

Work email & phone locked Unlock →

Matt Lipscomb

Founder

Work email & phone locked Unlock →

Mike Lynch

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts